NO150916C - Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat - Google Patents

Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat

Info

Publication number
NO150916C
NO150916C NO801285A NO801285A NO150916C NO 150916 C NO150916 C NO 150916C NO 801285 A NO801285 A NO 801285A NO 801285 A NO801285 A NO 801285A NO 150916 C NO150916 C NO 150916C
Authority
NO
Norway
Prior art keywords
phenoxypropanolamine
derivative
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO801285A
Other languages
English (en)
Norwegian (no)
Other versions
NO150916B (no
NO801285L (no
Inventor
Claude Gillet
Joseph Roba
Alexis Cordi
William Van Dorsser
Georges Lambelin
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of NO801285L publication Critical patent/NO801285L/no
Publication of NO150916B publication Critical patent/NO150916B/no
Publication of NO150916C publication Critical patent/NO150916C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO801285A 1979-05-04 1980-05-02 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat NO150916C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU81225 1979-05-04

Publications (3)

Publication Number Publication Date
NO801285L NO801285L (no) 1980-11-05
NO150916B NO150916B (no) 1984-10-01
NO150916C true NO150916C (no) 1985-01-16

Family

ID=19729148

Family Applications (2)

Application Number Title Priority Date Filing Date
NO801286A NO801286L (no) 1979-05-04 1980-05-02 Fremgangsmaate ved fremstilling av benzimidazolderivater
NO801285A NO150916C (no) 1979-05-04 1980-05-02 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO801286A NO801286L (no) 1979-05-04 1980-05-02 Fremgangsmaate ved fremstilling av benzimidazolderivater

Country Status (22)

Country Link
US (1) US4338330A (it)
JP (2) JPS6033424B2 (it)
AT (2) AT376210B (it)
AU (2) AU542596B2 (it)
BE (2) BE883069A (it)
CA (1) CA1146563A (it)
CH (2) CH644599A5 (it)
DE (2) DE3016828A1 (it)
DK (2) DK187980A (it)
ES (2) ES8104245A1 (it)
FI (2) FI801429A (it)
FR (2) FR2455572B1 (it)
GB (2) GB2055091B (it)
GR (2) GR68535B (it)
IE (1) IE50218B1 (it)
IL (2) IL59974A0 (it)
IT (2) IT1159060B (it)
NL (2) NL8002568A (it)
NO (2) NO801286L (it)
PT (2) PT71174A (it)
SE (2) SE8003277L (it)
ZA (2) ZA802694B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1156661A (en) * 1980-02-25 1983-11-08 Hoffmann-La Roche Limited Phenoxy-aminopropanol derivatives
JPS582343A (ja) * 1981-06-30 1983-01-07 Osaka Soda Co Ltd 耐窒素酸化物性に優れた加硫性ゴム組成物
GB8310556D0 (en) * 1983-04-19 1983-05-25 Beecham Group Plc Compounds
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
US5104892A (en) * 1989-12-11 1992-04-14 American Home Products Corporation Substituted benzimidazole derivatives possessing Class III antiarrhythmic activity
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
CN101172983A (zh) 2002-03-20 2008-05-07 麦它波莱克斯股份有限公司 取代的苯乙酸
US7351719B2 (en) 2002-10-31 2008-04-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
JP2008500357A (ja) * 2004-05-25 2008-01-10 メタボレックス インコーポレーティッド Ｐｐａｒのモジュレーターとしての置換されたトリアゾールおよびこれらの調製方法
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
EP2727911B1 (en) * 2012-10-31 2016-12-21 Medizinische Hochschule Hannover Novel means and methods for treating malaria and other parasitic disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157556A (en) * 1966-06-09 1969-07-09 Egyt Gyogyszervegyeszeti Gyar Novel Benzazole Derivatives and the Preparation thereof
FR1570892A (it) * 1968-06-18 1969-06-13
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
JPS5231858B1 (it) * 1969-12-17 1977-08-17
CH624395A5 (it) 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2640730C2 (de) * 1976-09-10 1983-08-25 Hoechst Ag, 6230 Frankfurt Benzoxazolyloxy- und Benzothiazolyloxy-phenoxy-Verbindungen und diese enthaltende herbizide Mittel
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2737630A1 (de) 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2801953A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE2801980A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0003758A1 (de) 1978-02-09 1979-09-05 Ciba-Geigy Ag Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2905877A1 (de) 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2905876A1 (de) 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
IL59973A (en) 1985-03-31
GB2055360B (en) 1983-07-06
ATA238780A (de) 1984-03-15
IE50218B1 (en) 1986-03-05
IT1159060B (it) 1987-02-25
BE883068A (fr) 1980-08-18
NL8002568A (nl) 1980-11-06
AU537573B2 (en) 1984-07-05
FI801428A (fi) 1980-11-05
SE8003277L (sv) 1980-11-05
IT1150018B (it) 1986-12-10
FR2455572B1 (fr) 1986-07-25
AU5809680A (en) 1980-11-06
IL59974A0 (en) 1980-07-31
ZA802695B (en) 1981-08-26
ES491142A0 (es) 1981-03-16
JPS6033424B2 (ja) 1985-08-02
FR2455572A1 (fr) 1980-11-28
NO801286L (no) 1980-11-05
NO150916B (no) 1984-10-01
DE3016828A1 (de) 1980-11-13
IE800918L (en) 1980-11-04
DK187980A (da) 1980-11-05
CH644599A5 (fr) 1984-08-15
PT71175A (fr) 1980-05-01
ATA238680A (de) 1984-04-15
ES491143A0 (es) 1981-04-16
ES8104245A1 (es) 1981-04-16
IL59973A0 (en) 1980-07-31
GR68536B (it) 1982-01-18
AT376210B (de) 1984-10-25
CA1146563A (en) 1983-05-17
CH645090A5 (fr) 1984-09-14
AU5809580A (en) 1980-11-06
GB2055091A (en) 1981-02-25
DK187880A (da) 1980-11-05
SE8003278L (sv) 1980-11-05
FR2455587A1 (fr) 1980-11-28
FI801429A (fi) 1980-11-05
GB2055091B (en) 1983-11-09
AU542596B2 (en) 1985-02-28
AT376418B (de) 1984-11-26
US4338330A (en) 1982-07-06
ZA802694B (en) 1981-08-26
NL8002567A (nl) 1980-11-06
JPS5663946A (en) 1981-05-30
PT71174A (fr) 1980-05-01
JPS565465A (en) 1981-01-20
NO801285L (no) 1980-11-05
IT8021779A1 (it) 1981-11-02
DE3016827A1 (de) 1980-11-20
FR2455587B1 (it) 1983-06-24
GB2055360A (en) 1981-03-04
GR68535B (it) 1982-01-18
IT8021779A0 (it) 1980-05-02
IT8021780A1 (it) 1981-11-02
BE883069A (fr) 1980-08-18
IT8021780A0 (it) 1980-05-02
ES8103729A1 (es) 1981-03-16

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO150916C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO150762C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-aza-2-(2,2,2)-bicyklo-oktan
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO152128C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO153258C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner